Ibudilast and Impurities
Ibudilast
CAS:50847-11-5
Formula:
C14H18N2O
Color and Shape:
White To Off-White Solid
Molecular weight:
230.31
Ref: 4Z-I-311
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ibudilast-d7
CAS:50847-11-5
Formula:
C14H11D7N2O
Color and Shape:
White To Off-White Solid
Molecular weight:
237.35
Ref: 4Z-I-312
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 4Z-I-314
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Ibudilast
CAS:50847-11-5
Ibudilast (MN-166)(KC-404;AV-411;MN-166) is a relatively nonselective phosphodiesterase inhibitor. It is approved for use as an …
Formula:
C14H18N2O
Purity:
99.34% - 99.94%
Color and Shape:
White Solid
Molecular weight:
230.31
Ref: TM-T2137
10mg | 46.00 € | ||
25mg | 52.00 € | ||
50mg | 56.00 € | ||
100mg | 84.00 € | ||
200mg | 97.00 € | ||
1mL*10mM (DMSO) | 49.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Ref: 4Z-I-313
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Ibudilast-d7
Controlled ProductCAS:50847-11-5
Applications Ibudilast-d7 is the labeled analogue of Ibudilast (I125000), a leukotriene D4 antagonist. Used as …
Formula:
C14H11D7N2O
Color and Shape:
Neat
Molecular weight:
237.35
Ref: TR-I125003
1mg | 324.00 € | ||
10mg | 2,136.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
Ibudilast
Controlled ProductCAS:50847-11-5
Applications A leukotriene D4 antagonist. Used as an antiallergic, antiasthmatic, and vasodilator (cerebral). PDE inhibitor …
Formula:
C14H18N2O
Color and Shape:
Neat
Molecular weight:
230.31
Ref: TR-I125000
1g | 315.00 € | ||
25mg | 91.00 € | ||
100mg | 140.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025